72599-27-0
72599-27-0
Chemical Structure
Miglustat
Synonym(s): N-Butyldeoxynojirimycin; NB-DNJ; OGT 918
- CAS No.: 72599-27-0
- Formula:C10H21NO4
- Molecular Weight:219.28
IUPAC Name: (2R,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol
InChIKey: UQRORFVVSGFNRO-UTINFBMNSA-N
SMILES: O[C@H]1[C@H](O)[C@@H](CO)N(CCCC)C[C@@H]1O
Biological Activity: Miglustat (N-Butyldeoxynojirimycin) is an orally active and reversible ceramide glucosyltransferase inhibitor. Miglustat can be used for the research of type I gaucher disease[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Miglustat | 99.99% | Miglustat (N-Butyldeoxynojirimycin) is an orally active and reversible ceramide glucosyltransferase inhibitor. Miglustat can be used for the research of type I gaucher disease. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Miglustat (Standard) | ≥98% | Miglustat (Standard) is the analytical standard of Miglustat. This product is intended for research and analytical applications. Miglustat (N-Butyldeoxynojirimycin) is an orally active and reversible ceramide glucosyltransferase inhibitor. Miglustat can be used for the research of type I gaucher disease. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Miglustat-d9 | Miglustat-d9 is the deuterium labeled Miglustat. Miglustat (N-Butyldeoxynojirimycin) is an inhibitor of glucosylceramide synthase, primarily to treat Type I Gaucher disease (GD1). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
